A detailed history of Payden & Rygel Investment Group transactions in Johnson & Johnson stock. As of the latest transaction made, Payden & Rygel Investment Group holds 90,900 shares of JNJ stock, worth $13.2 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
90,900
Previous 78,300 16.09%
Holding current value
$13.2 Million
Previous $12.2 Million 17.91%
% of portfolio
0.68%
Previous 0.83%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $1.96 Million - $2.05 Million
12,600 Added 16.09%
90,900 $14.4 Million
Q3 2023

Nov 08, 2023

BUY
$155.75 - $174.48 $12.2 Million - $13.7 Million
78,300 New
78,300 $12.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Payden & Rygel Investment Group Portfolio

Follow Payden & Rygel Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel Investment Group with notifications on news.